Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Combined inhibition of PI3 kinase and EGFR overcomes the intrinsic apoptosis resistance of PTEN-null cancer cells and suppresses their xenograft growth
    Meeting Abstract

    She, Q. B.; Solit, D.; Ye, Q.; O'reilly, K.; Rosen, N.
    Cancer Research (2005)

    Fulltext@MSK | Save
  • Cyclin D expression and G1 progression are dependent on MEK MAP kinase activity in tumor cells with B-Raf mutation but not in breast cancer cells with wild type Ras and Raf
    Meeting Abstract

    Sawai, A.; Pratilas, C.; Basso, A.; Rosen, N.; Solit, D. B.
    Cancer Research (2005)

    Fulltext@MSK | Save
  • The MEK inhibitor PD0325901 completely inhibits the growth of melanoma tumors with mutationally activated B-Raf
    Meeting Abstract

    Pratilas, C.; Sawai, A.; Ye, Q.; Lobo, J.; She, Y.; Sebolt-Leopold, J.; Rosen, N.; Solit, D.
    Cancer Research (2005)

    Fulltext@MSK | Save
  • The IGF-1 dependent feedback activation of AKT
    Meeting Abstract

    Oreilly, K. E.; She, Q. B.; Solit, D.; Lane, H.; Hofmann, F.; Hicklin, D. J.; Baselga, J.; Rosen, N.
    Cancer Research (2005)

    Fulltext@MSK | Save
  • Optimizing chemotherapeutic dose-schedule (CDS) by Norton-Simon modeling: Capecitabine (Xeloda (R) = X)
    Meeting Abstract

    Norton, L.; Dugan, U.; Young, D.; Farrell, C.; Tanaka, Y.; Theodoulou, M.; Traina, T.; Hudis, C.
    Cancer Research (2005)

    Fulltext@MSK | Save
  • V599E B-Raf as the next HSP90 client protein: A novel strategy for selective inhibition of mutated B-Raf
    Meeting Abstract

    Grbovic, O. M.; Basso, A.; Solit, D.; Rosen, N.
    Cancer Research (2005)

    Fulltext@MSK | Save
  • Treatment of melanoma patients with 17AAG results in downregulation of the MAPK pathway in the melanoma tumors
    Meeting Abstract

    Friedlander, P.; Solit, D.; Osman, I.; Polsky, D.; Elamparo, R.; Rosen, N.; Chapman, P. B.
    Cancer Research (2005)

    Fulltext@MSK | Save
  • Estrogen receptor-negative breast cancer with an active hormone response pathway: Therapeutic implications
    Meeting Abstract

    Doane, A. S.; Danso, M.; Lal, P.; Donaton, M.; Zhang, L.; Hudis, C.; Gerald, W. L.
    Cancer Research (2005)

    Fulltext@MSK | Save
  • Evaluation of 8-arylsulfanyl, 8-arylsulfoxyl and 8-arylsulfonyl adenine derivatives as inhibitors of the heat shock protein 90
    Meeting Abstract

    Chiosis, G.; He, H.; Llauger, L.; Rosen, N.; Kim, J.; Aguirre, J.
    Cancer Research (2005)

    Fulltext@MSK | Save
  • Systemic treatment for stage I and stage II breast cancer
    Book Section

    Hudis, C. A.; Norton, L.
    In Roses, D. F. (Eds.) Breast Cancer. 2nd ed (2005)

    Fulltext@MSK | Save